Skip to content
DataLookout
Menu

Hyundai Bioscience Co., Ltd. clinical trial pipeline

Get alerts when Hyundai Bioscience Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  1. Notable: CP-PCA07 in Combination With Enzalutamide · Castration-Resistant Prostate Cancer Recruitment opened Hyundai Bioscience Co., Ltd.Phase 1 NCT07683013
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Active trials by phase

Phase 1
1
Phase 2/3
1

Disease areas by active trials

Get alerts when Hyundai Bioscience Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free